A novel use of thromboelastography in type 2B von Willebrand disease.

[No abstract available]356e11e14Hampshire, D.J., Goodeve, A.C., The international society on thrombosis and haematosis von Willebrand disease database: an update (2011) Semin Thromb Hemost, 37, pp. 470-479Von Willebrand disease mutation database, , http://www.vwf.group.shef.ac.uk/, Accessed 23 October 2011Othman, M., Favaloro, E.J., Genetics of type 2B von Willebrand disease: "true 2B", "tricky 2B", or "not 2B". What are the modifiers of the phenotype? (2008) Semin Thromb Hemost, 34, pp. 520-531Nurden, P., Debili, N., Vainchenker, W., Bobe, R., Bredoux, R., Corvazier, E., Combrie, R., Enouf, J., Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia (2006) Blood, 108, pp. 2587-2595Federici, A.B., Mannucci, P.M., Stabile, F., Canciani, M.T., Di Rocco, N., Miyata, S., Ware, J., Ruggeri, Z.M., A type 2b von Willebrand disease mutation (Ile546->Val) associated with an unusual phenotype (1997) Thromb Haemost, 78, pp. 1132-1137Takimoto, Y., Imanaka, F., Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma (1999) Int J Hematol, 70, pp. 127-131Castaman, G., Eikenboom, J.C., ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854GIn, and the missense mutation Cys2362Phe (2002) Blood, 100, pp. 1927-1928Yuan, Z.H., Zhao, J., Zhang, Y., Zhu, P., [Impact of vWF gene A1381T polymorphism and ABO blood group on von Willebrand factor level in plasma] (2010) Zhongguo Shi Yan Xue Ye Xue Za Zhi, 18, pp. 967-971Fleming, A.F., Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease (2003) Clin Lab Haematol, 25, p. 413Miesbach, W., Berntorp, E., When von Willebrand disease comes into age - a matter of change? (2011) Eur J Haematol, 86, pp. 496-501Ruggeri, Z.M., Mannucci, P.M., Lombardi, R., Federici, A.B., Zimmerman, T.S., Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes (1982) Blood, 59, pp. 1272-1278Nichols, W.L., Hultin, M.B., James, A.H., Manco-Johnson, M.J., Montgomery, R.R., Ortel, T.L., Add Rick, M.E., Yawn, B.P., von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) (2008) Haemophilia, 14, pp. 171-232Chen, A., Teruya, J., Global hemostasis testing thromboelastography: old technology, new applications (2009) Clin Lab Med, 29, pp. 391-407Stammers, A.H., Bruda, N.L., Gonano, C., Hartmann, T., Point-of-care coagulation monitoring: applications of the thromboelastography (1998) Anaesthesia, 53 (SUPPL. 2), pp. 58-59Chitlur, M., Sorensen, B., Rivard, G.E., Young, G., Ingerslev, J., Othman, M., Nugent, D., Lusher, J., Standardization of thromboelastography: a report from the TEG-ROTEM working group (2011) Haemophilia, 17, pp. 532-537Chitlur, M., Lusher, J., Standardization of thromboelastography: values and challenges (2010) Semin Thromb Hemost, 36, pp. 707-711Topf, H.G., Weiss, D., Lischetzki, G., Strasser, E., Rascher, W., Rauh, M., Evaluation of a modified thromboelastography assay for the screening of von Willebrand disease (2011) Thromb Haemost, 105, pp. 1091-109